Skip to main content
Veterinary Medicines

DROCAINA

Authorised
  • Epinephrine
  • Lidocaine hydrochloride

Product identification

Medicine name:
DROCAINA
Active substance:
  • Epinephrine
  • Lidocaine hydrochloride
Target species:
  • Horse
  • Dog
  • Cat
Route of administration:
  • Epidural use
  • Subcutaneous use

Product details

Active substance and strength:
  • Epinephrine
    10.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Lidocaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Epidural use
    • Horse
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        day
  • Subcutaneous use
    • Horse
      • Meat and offal
        0
        day
    • Dog
    • Cat
    • Horse
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB52
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetia Animal Health S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • CZ Vaccines S.A.U.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 816 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."